V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161460 | 20062429 | 1.87 | 96 | Palliative (P) | 2019-07-17 | 2019-07-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100339144 |
| 20161462 | 20062430 | 1.72 | 77 | Neo-adjuvant (N) | 2019-12-27 | 2019-12-31 | ECX | N | Y | ECX | 100226525 |
| 20161463 | 20062431 | 1.56 | 95.9 | Adjuvant (A) | 2019-07-01 | 2019-07-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100135195 |
| 20161464 | 20062432 | 1.76 | 55.8 | Adjuvant (A) | 2018-08-15 | 2018-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100713481 |
| 20161467 | 20062433 | 1.61 | 74 | null | 2018-09-08 | 2018-09-20 | ECX | N | N | ECX | 101542676 |
| 20161468 | 20062434 | 1.62 | 118.2 | Neo-adjuvant (N) | 2019-11-05 | 2019-11-07 | ECX | N | N | ECX | 101194034 |
| 20161472 | 20062435 | 1.69 | 60.7 | Adjuvant (A) | 2016-08-13 | 2016-08-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101539859 |
| 20161473 | 20062436 | 1.71 | 80 | Curative (C) | 2016-12-03 | 2017-01-14 | ECX | N | N | ECX | 100820602 |
| 20161474 | 20062437 | 1.78 | 88.3 | Adjuvant (A) | 2017-09-06 | 2017-09-06 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100226114 |
| 20161475 | 20062438 | 1.71 | 62.3 | Adjuvant (A) | 2018-07-08 | 2018-07-08 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101493562 |
| 20161476 | 20062439 | 1.62 | 89 | Palliative (P) | 2016-04-20 | 2016-04-23 | ECX | N | N | ECX | 100310087 |
| 20161477 | 20062440 | 1.75 | 59.6 | Neo-adjuvant (N) | 2017-07-06 | 2017-07-13 | ECX | N | N | ECX | 101853629 |
| 20161480 | 20062441 | null | 72.8 | Palliative (P) | 2017-05-27 | 2017-06-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100373115 |
| 20161481 | 20062442 | 1.63 | 66.8 | Adjuvant (A) | 2019-11-05 | 2019-11-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100060467 |
| 20161482 | 20062443 | 1.8 | 103 | Adjuvant (A) | 2019-10-01 | 2019-10-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101736726 |
| 20161483 | 20062444 | 1.72 | 73 | null | 2017-05-08 | 2017-05-19 | ECX | 02 | Y | ECX | 101188898 |
| 20161484 | 20062445 | 1.68 | 65 | Neo-adjuvant (N) | 2016-09-24 | 2016-11-11 | ECX | N | N | ECX | 101629889 |
| 20161485 | 20062446 | 1.52 | 66 | Adjuvant (A) | 2018-10-08 | 2018-10-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101061788 |
| 20161487 | 20062447 | 1.64 | 59.3 | Neo-adjuvant (N) | 2018-12-08 | 2018-12-18 | ECX | N | N | ECX | 100584032 |
| 20161488 | 20062448 | 1.8 | 72.85 | Neo-adjuvant (N) | 2017-11-08 | 2017-11-09 | ECX | 02 | null | ECX | 101602017 |
| 20161489 | 20062449 | 1.66 | 57.4 | Palliative (P) | 2019-07-24 | 2019-07-24 | ECX | 2 | N | ECX | 100682188 |
| 20161490 | 20062450 | 1.83 | 89.65 | Palliative (P) | 2019-11-18 | 2019-11-27 | ECX | null | N | ECX | 100956464 |
| 20161492 | 20062451 | null | 62.3 | Neo-adjuvant (N) | 2017-01-15 | 2017-01-20 | ECX | N | N | ECX | 101061576 |
| 20161493 | 20062452 | 1.65 | 54.8 | Neo-adjuvant (N) | 2019-08-03 | 2019-08-07 | ECX | 02 | N | ECX | 100429635 |
| 20161494 | 20062453 | 1.58 | 71.7 | Palliative (P) | 2017-11-03 | 2017-11-18 | ECX | N | N | ECX | 100674695 |
| 20161496 | 20062454 | 1.77 | 96 | Adjuvant (A) | 2016-10-20 | 2018-02-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101100446 |
| 20161497 | 20062455 | 1.79 | 77.6 | Curative (C) | 2019-07-31 | 2019-07-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101641954 |
| 20161498 | 20062456 | 1.7 | 52 | Neo-adjuvant (N) | null | 2018-01-15 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100567499 |
| 20161499 | 20062457 | 1.6 | 76.9 | Adjuvant (A) | 2017-10-03 | 2017-10-19 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101197742 |
| 20161501 | 20062458 | 1.76 | 99 | Palliative (P) | 2019-09-02 | 2019-09-25 | ECX | 02 | null | ECX | 101171312 |
| 20161502 | 20062459 | 1.9 | 66.7 | Palliative (P) | 2018-07-02 | 2018-07-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101057467 |
| 20161504 | 20062460 | 1.7 | 80.4 | Neo-adjuvant (N) | 2019-08-07 | 2019-08-26 | ECX | N | N | ECX | 101720553 |
| 20161505 | 20062461 | 1.46 | 57.4 | Palliative (P) | 2018-11-15 | 2018-11-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101094417 |
| 20161507 | 20062462 | null | null | Neo-adjuvant (N) | null | 2019-09-08 | ECX | N | N | ECX | 100863355 |
| 20161508 | 20062463 | 1.73 | 86 | Adjuvant (A) | 2017-02-25 | 2017-02-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101113449 |
| 20161509 | 20062464 | 1.56 | 55.8 | Neo-adjuvant (N) | 2016-07-16 | 2016-07-30 | ECX | 2 | N | ECX | 101098380 |
| 20161510 | 20062465 | 1.7 | 82.6 | Palliative (P) | 2018-06-03 | 2018-06-17 | ECX | 2 | N | ECX | 101264206 |
| 20161512 | 20062466 | 1.68 | 57 | null | null | 2019-01-08 | ECX | null | null | ECX | 100002028 |
| 20161513 | 20062467 | 1.63 | null | Palliative (P) | 2016-06-19 | 2016-06-27 | ECX | N | N | ECX | 101566341 |
| 20161514 | 20062468 | 1.8 | 93.3 | Neo-adjuvant (N) | 2020-02-14 | 2020-02-17 | ECX | N | N | ECX | 101735520 |
| 20161515 | 20062469 | 1.62 | 63 | Neo-adjuvant (N) | 2019-04-22 | 2019-04-29 | ECX | N | N | ECX | 100211499 |
| 20161519 | 20062470 | 1.74 | null | Adjuvant (A) | 2018-09-12 | 2018-09-12 | ECX | 02 | N | ECX | 100109028 |
| 20161520 | 20062471 | 1.8 | 84.6 | Palliative (P) | 2018-02-05 | 2018-02-19 | ECX | 02 | N | ECX | 101125202 |
| 20161522 | 20062472 | 1.69 | 53.9 | Curative (C) | 2016-03-30 | 2016-04-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100625914 |
| 20161523 | 20062473 | 1.73 | 52.85 | Adjuvant (A) | 2017-06-03 | 2017-06-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101640545 |
| 20161524 | 20062474 | 1.72 | 68.9 | Curative (C) | 2016-10-14 | 2016-10-14 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100064496 |
| 20161527 | 20062475 | 1.49 | 67.9 | Adjuvant (A) | 2019-06-26 | 2019-07-09 | ECX | null | N | ECX | 101331093 |
| 20161528 | 20062476 | 1.75 | 76.2 | Neo-adjuvant (N) | 2018-04-23 | 2018-05-05 | ECX | N | Y | ECX | 100346553 |
| 20161529 | 20062477 | 1.77 | 48.5 | Neo-adjuvant (N) | null | 2016-02-22 | ECX | N | N | ECX | 101178461 |
| 20161530 | 20062478 | 1.59 | 56 | Adjuvant (A) | 2019-01-10 | 2019-01-18 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100671496 |